Forgot your password?
Document Actions
leukemia_publicationseeker
Up one level| Title | Description |
|---|---|
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
|
Gattei V, Bulian P, Del Principe MI, Zucchetto A, Maurillo L, Buccisano F, Bomben R, Dal Bo M, Luciano F, Rossi FM, Degan M, Amadori S, Del Poeta G. Relevance... |
|
How would i manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukemia?
|
Bulian P, Del Poeta G and Gattei V. How would i manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukemia? Hematol Onc... |
|
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukemia and is recapitulated by biological risk factors
|
Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V, Gozzetti A, Tassi M, Cencini E, Raspadori D, Bertoni F, Gattei V, Lauria F, Gaidano G, Forconi F. The pr... |
|
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to Nutlin-3 induces a characteristic gene expression profile, which correlates with Nutlin-3-mediated cytotoxicity
|
Zauli G, di Iasio MG, Secchiero P, Dal Bo M, Marconi D, Bomben R, Del Poeta G, Gattei V. Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to Nutli... |
|
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/VCAM-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival
|
Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S,... |
|
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia
|
Gattei V, Bulian P, et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. B... |
|
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia
|
Rossi D, Zucchetto A, Rossi F. M, Capello D, Cerri M, Deambrogi C, Cresta S, Rasi S, De Paoli L,Lobetti Bodoni C, Bulian P, Del Poeta G, Ladetto M, Gattei V, G... |
|
Are surrogates of IGHV genemutational status useful in B-cell chronic lymphocytic leukemia?
|
Benedetti D, Bomben R, et al. Are surrogates of IGHV genemutational status useful in B-cell chronic lymphocytic leukemia? Leucemia. 2008. 22: 224–226 |
|
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia
|
Del Poeta G, Del Principe MI, Buccisano F, Maurillo L, Capelli G, Luciano F, Perrotti AP, Degan M, Venditti A, de Fabritiis P, Gattei V, Amadori S. Consolidati... |
Subscribe to News mailing list